ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Yi Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9675-5998; OpenAlex author ID A5102784101. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Macrophage-derived exosomal microRNAs promote metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.intimp.2024.111590 ↗
Investigation of the potential role of TGR5 in pancreatic cancer by a comprehensive molecular experiments and the liquid chromatography mass spectrometry (LC-M… Co-author DOI 10.1007/s12672-022-00504-2 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yangyang Lei · 2 shared papers, 2022–2024 · strength 0.43
- Paper Macrophage-derived exosomal microRNAs promote metastasis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.intimp.2024.111590 ↗
- Paper Investigation of the potential role of TGR5 in pancreatic cancer by a comprehensive molecular experiments and the liqui… DOI 10.1007/s12672-022-00504-2 ↗
G Li · 1 shared paper, 2024 · strength 0.28
- Paper Macrophage-derived exosomal microRNAs promote metastasis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.intimp.2024.111590 ↗
Xiaolin Wang · 1 shared paper, 2024 · strength 0.28
- Paper Macrophage-derived exosomal microRNAs promote metastasis in pancreatic ductal adenocarcinoma. DOI 10.1016/j.intimp.2024.111590 ↗
Shanshan Gao · 1 shared paper, 2022 · strength 0.15
- Paper Investigation of the potential role of TGR5 in pancreatic cancer by a comprehensive molecular experiments and the liqui… DOI 10.1007/s12672-022-00504-2 ↗
Xiaolin Wang · 1 shared paper, 2022 · strength 0.15
- Paper Investigation of the potential role of TGR5 in pancreatic cancer by a comprehensive molecular experiments and the liqui… DOI 10.1007/s12672-022-00504-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.